Biotech Values

[CHM_760]

The White House reports that only a meeting on the subject is taking place; no assurance of an actual Executive Order.

I own a couple of biotechs that are especially sensitive to rumors about price controls (ACAD for one).

In today's world, just the mention of a meeting is enough to dump the IBB/XBI by 2%-3% in a matter of minutes, which is when I posted that little blurb.